The latest research from the American Institute for Cancer Research and the World Cancer Research Fund highlights several factors that increase the risk of stomach cancer.
Researchers have pinpointed various drugs typically used to treat diseases such as heart failure and infections that could also be beneficial in treating cancers.
The FDA has granted accelerated approval to linvoseltamab-gcpt, a BCMA-directed bispecific T-cell engager, offering a new option for patients with heavily pretreated relapsed or refractory multiple myeloma....
A new analysis from Western Washington investigators suggests that adverse financial events at diagnosis may delay treatment initiation for patients with hematologic malignancies, highlighting a potential...
